Previous 10 | Next 10 |
2024-06-06 10:09:40 ET More on Eli Lilly Is It Possible Eli Lilly Is Breaking Out To New All-Time Highs? Eli Lilly and Company (LLY) Lilly Oncology ASCO Investor Event (Transcript) Eli Lilly's Growth And Challenges: A Cautious Buy Eli Lilly snaps six straight...
A look at the top 10 most actives in the United States Nauticus Robotics Inc. (KITT) rose 29.5% to $0.1787 on volume of 92,016,620 shares Freight Technologies Inc. (FRGT) rose 92.0% to $1.2 on volume of 65,878,105 shares Aethlon Medical Inc. (AEMD) rose 68.2% to $0.7379 on volume of 48,98...
2024-06-06 09:07:10 ET Summary AstraZeneca PLC showcased projects in two plenary lecture presentations at the Annual Meeting of the American Society of Clinical Oncology, or ASCO, including a trial that established osimertinib as the standard of care for EGFR-mutant NSCLC. Bristol...
2024-06-06 08:35:51 ET Summary Considering the Fed's close watch on labor market figures, the May figures will be key as they may well confirm that a slowdown is indeed underway. After a weak April, the employment situation is forecast to be sluggish again. This ties in with muted...
2024-06-05 16:22:38 ET Eli Lilly ( NYSE: LLY ) shares traded in the red on Wednesday, breaking a streak of six straight days of gains. Stock closed down 0.10% at $831.76.... Read the full article on Seeking Alpha For further details see: Eli Lilly snaps six straight ...
2024-06-05 14:05:17 ET Summary Eli Lilly has been outperforming the S&P 500. The company's blockbuster drug Mounjaro has been approved in China, resulting in high demand and a strong earnings report. The five-year target price for Eli Lilly has been raised to $1,455 based ...
2024-06-05 13:44:31 ET More on LifeMD LifeMD: Moving Towards Profitability LifeMD, Inc. (LFMD) Q1 2024 Earnings Call Transcript LifeMD, Inc. 2024 Q1 - Results - Earnings Call Presentation LifeMD Q1 2024 Earnings Preview LifeMD Non-GAAP EPS of $0.15 be...
2024-06-05 13:10:12 ET More on Biogen, Eli Lilly, etc. Eli Lilly and Company (LLY) Lilly Oncology ASCO Investor Event (Transcript) Eli Lilly's Growth And Challenges: A Cautious Buy Eli Lilly: Addressing Supply Challenges Should Accelerate Growth Alphabet taps...
2024-06-05 13:00:00 ET Summary The "Undercovered" Dozen highlights twelve ideas from the previous month on stocks with limited coverage. Albertsons, Viking Therapeutics, Brandywine Realty Trust, platinum, and more are discussed in this edition. A number of veteran Seeking Alph...
2024-06-05 08:21:51 ET Google’s parent company Alphabet ( NASDAQ: GOOG ) ( NASDAQ: GOOGL ) has tapped Anat Ashkenazi as its new chief financial officer.... Read the full article on Seeking Alpha For further details see: Alphabet taps Eli Lilly executiv...
News, Short Squeeze, Breakout and More Instantly...
2024-07-29 09:20:00 ET While the market for anti-obesity medicines is characterized today by a fight between Novo Nordisk 's (NYSE: NVO) drug Wegovy and Eli Lilly 's (NYSE: LLY) drug Zepbound, that won't always be the case. Over the coming years, the competitive dynamics of ...
2024-07-29 07:30:00 ET When a major player announces good news in a lucrative market like weight loss drugs, it's often enough to drive shares of competitors down based on the assumption that they will have struggles ahead. That's just what happened after an announcement by Roche Hold...
2024-07-27 07:15:00 ET According to some research, bull markets tend to last an average of 2.6 years. The one we are currently experiencing has been going on for almost two years -- maybe it will soon end, maybe it won't. Equities that can perform well throughout bull runs might be good to ...